Gene Transfer of the Catabolic Inhibitor TIMP-1 Increases Measured Proteoglycans in Cells from Degenerated Human Intervertebral Discs
暂无分享,去创建一个
Lars G. Gilbertson | Paul Robbins | James D. Kang | L. Gilbertson | P. Robbins | H. Georgescu | Satoshi Sobajima | Corey J. Wallach | Yasuhiko Watanabe | Joseph S. Kim | Helga I. Georgescu | S. Sobajima | C. Wallach | Yasu Watanabe
[1] J. P. Thompson,et al. Stimulation of Mature Canine Intervertebral Disc by Growth Factors , 1991, Spine.
[2] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.
[3] E. Lavallie,et al. ADAMTS4 Cleaves at the Aggrecanase Site (Glu373-Ala374) and Secondarily at the Matrix Metalloproteinase Site (Asn341-Phe342) in the Aggrecan Interglobular Domain* , 2002, The Journal of Biological Chemistry.
[4] G. Waddell. Low Back Pain: A Twentieth Century Health Care Enigma , 1996, Spine.
[5] A. Roessner,et al. Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. , 1998, Pathology, research and practice.
[6] A. Maroudas,et al. Glycosaminoglycan turn-over in articular cartilage. , 1975, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[7] James D. Kang,et al. Adenovirus‐Mediated Gene Transfer to Nucleus Pulposus Cells: Implications for the Treatment of Intervertebral Disc Degeneration , 1998, Spine.
[8] H. Tsuji,et al. Effects of Hydrostatic Pressure on Matrix Synthesis and Matrix Metalloproteinase Production in the Human Lumbar Intervertebral Disc , 1997, Spine.
[9] James D. Kang,et al. Human Intervertebral Disc Cells Are Genetically Modifiable by Adenovirus-Mediated Gene Transfer: Implications for the Clinical Management of Intervertebral Disc Disorders , 2000, Spine.
[10] M. Perricaudet,et al. Advances in adenoviral vectors: from genetic engineering to their biology , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] B. Trapnell,et al. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.
[12] J A Anderson,et al. Epidemiological aspects of back pain. , 1986, The Journal of the Society of Occupational Medicine.
[13] J. Urban,et al. Swelling pressure of the inervertebral disc: influence of proteoglycan and collagen contents. , 1985, Biorheology.
[14] J A Buckwalter,et al. Aging and degeneration of the human intervertebral disc. , 1995, Spine.
[15] P. Robbins,et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene , 2000, Gene Therapy.
[16] James D. Kang,et al. Herniated Lumbar Intervertebral Discs Spontaneously Produce Matrix Metalloproteinases, Nitric Oxide, Interleukin-6, and Prostaglandin E2 , 1996, Spine.
[17] B. Caterson,et al. Matrix Metalloproteinases And Aggrecanase: Their Role in Disorders of the Human Intervertebral Disc , 2000, Spine.
[18] J. Urban,et al. Swelling Pressure of the Lumbar Intervertebral Discs: Influence of Age, Spinal Level, Composition, and Degeneration , 1988, Spine.
[19] James D. Kang,et al. Herniated Cervical Intervertebral Discs Spontaneously Produce Matrix Metalloproteinases, Nitric Oxide, Interleukin‐6, and Prostaglandin E2 , 1995, Spine.
[20] D. Borenstein. Epidemiology, etiology, diagnostic evaluation, and treatment of low back pain. , 1998, Current opinion in rheumatology.
[21] K. Brew,et al. Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.
[22] M. E. Adams,et al. Degeneration and the chemical composition of the human lumbar intervertebral disc , 1987, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[23] C. Evans,et al. Potential of gene therapy for treating osteogenesis imperfecta. , 2000, Clinical orthopaedics and related research.
[24] N. Fujimoto,et al. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[25] K. Tanzawa,et al. Inhibition of ADAMTS4 (aggrecanase‐1) by tissue inhibitors of metalloproteinases (TIMP‐1, 2, 3 and 4) , 2001, FEBS letters.
[26] L G Gilbertson,et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. , 1999, Spine.
[27] T. Oegema,et al. Identification of heterogeneous cell populations in normal human intervertebral disc. , 1995, Journal of anatomy.
[28] S. Hukuda,et al. Immunohistochemical Study of Matrix Metalloproteinase‐3 and Tissue Inhibitor of Metalloproteinase‐1 in Human Intervertebral Discs , 1996, Spine.
[29] E. Lechman,et al. Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. , 2000, Arthritis and rheumatism.
[30] James D. Kang,et al. New Use of a Three-Dimensional Pellet Culture System for Human Intervertebral Disc Cells: Initial Characterization and Potential Use for Tissue Engineering , 2001, Spine.
[31] J. Adler,et al. Early Onset of Disk Degeneration and Spondylosis in Sand Rats (Psammomys Obesus) , 1983, Veterinary pathology.
[32] G. Andersson,et al. Discs Degenerate Before Facets , 1990, Spine.
[33] J. Kraemer. Natural course and prognosis of intervertebral disc diseases. International Society for the Study of the Lumbar Spine Seattle, Washington, June 1994. , 1995, Spine.
[34] A. Poole,et al. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[35] T. Martin,et al. Therapeutic approaches to bone diseases. , 2000, Science.